Business ❯Finance ❯Pharmaceuticals

Drug Sales

COVID-19 Products Weight Loss Drugs Mounjaro and Zepbound Eli Lilly Bristol Myers Squibb Weight-loss Drugs Eli Lilly's Forecast AbbVie Mounjaro Specific Drugs

4 ARTICLES

5mo ago

AbbVie Reports Strong Sales Growth for Skyrizi and Rinvoq, Boosts 2027 Revenue Outlook

The pharmaceutical giant's fourth-quarter performance exceeded expectations, offsetting sharp declines in Humira sales with surging demand for its newer immunology drugs.

5 ARTICLES

6mo ago

Eli Lilly's Q1 Earnings Surge on Strong Zepbound and Mounjaro Sales

Drug Sales

AbbVie Reports Strong Sales Growth for Skyrizi and Rinvoq, Boosts 2027 Revenue Outlook

Eli Lilly Lowers 2024 Revenue Forecast Due to Slower Weight-Loss Drug Growth

Bristol Myers Squibb Surpasses Q3 Expectations, Raises 2024 Outlook

Eli Lilly's Weight-Loss Drugs Drive Record Q2 Revenue Surge

Pfizer and Merck Diverge in Q2 Performance Amid Revised Forecasts

Eli Lilly's Q1 Earnings Surge on Strong Zepbound and Mounjaro Sales